Drawing for AFFICHROM'

USPTO serial 79282245

AFFICHROM'

Reviewed by CopyMark Law Group

Reg. 6297543Status 700Renewal
Filing date
Status date
Registration date
Mar 23, 2021
Examiner
TARASCIO, MAUREEN J
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AFFICHROM'?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,544*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michelle L. Visser

Michelle L. Visser Fishman Stewart PLLC800 Tower Drive, Suite 610Troy, MI 48098UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical reagents, other than for medical and veterinary use; chemical diagnostic reagents for industrial use; chemical substances intended for separation of proteins other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical products for the purification of proteins for in-vitro use; media for chromatography other than for medical use, namely, for separation of a mixture into components; chromatography media for scientific laboratories, namely, for separation of a mixture into components; diagnostic laboratory reagents for scientific use; diagnostic reagents for scientific use or for research; proteins in raw material form for scientific research purposes; chemical products for use in scientific diagnosis, not for medical or veterinary purposes; biochemical products for in-vitro and in-vivo scientific use; proteins for use in industry; chemical products for use in chromatography, other than for medical or veterinary useACTIVE—
005Biochemical preparations for medical use, namely, for the detection and the diagnosis of cancers, inflammation, neurologic disorders, immune system related diseases and disorders; diagnostic preparations for medical purposes; reagents for medical use; biological reagents for medical use; reagents and substances for medical and veterinary diagnostic purposes; diagnostic reagents for medical use; chemical reagents for medical or veterinary useACTIVE—
009Diagnostic apparatus for the detection of pathogens, allergens and contaminants for laboratory or research use and not for medical use; testing apparatus not for medical use, namely, electronic analyzers for testing chemical and biological substances for the presence, absence, or quantity of target chemicals, biologics and contaminants; scientific apparatus and instruments for measuring relative DNA, RNA and proteins and parts and fittings therefor; chromatography apparatus for laboratory or scientific use; separation apparatus for laboratories, namely, pre-packed columns, laboratory filters and hollow fiber membranes for use in separation; chromatography columns for laboratory use; separation columns for scientific purposesACTIVE—
010Separation instruments, namely, gas chromatography apparatus for medical use; chromatography instruments for medical use; chromatography columns for medical use; affinity chromatography columns for medical useACTIVE—
011Chromatography columns for industrial use; chromatography apparatus for industrial useACTIVE—
042Medical and pharmacological research services; scientific laboratory services; biological laboratory services; research and development in the field of biotechnology; research and development for the pharmaceutical industry; research and development of new products; scientific research and developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 23, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 18, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 29, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 29, 2021FIMPFINAL DISPOSITION PROCESSED—
Jun 23, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 23, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 10, 2021GPNXNOTIFICATION PROCESSED BY IB—
Jan 5, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 5, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 23, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 23, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 16, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 2, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 1, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Dec 1, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 1, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 1, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 19, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 18, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 18, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 18, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 18, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 18, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 18, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 18, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 18, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 19, 2020RFNTREFUSAL PROCESSED BY IB—
May 29, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 28, 2020RFRRREFUSAL PROCESSED BY MPU—
May 9, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 8, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2020DOCKASSIGNED TO EXAMINER—
Apr 7, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 3, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 2, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance